These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 30967527)

  • 61. MIAT promotes proliferation and hinders apoptosis by modulating miR-181b/STAT3 axis in ox-LDL-induced atherosclerosis cell models.
    Zhong X; Ma X; Zhang L; Li Y; Li Y; He R
    Biomed Pharmacother; 2018 Jan; 97():1078-1085. PubMed ID: 29136944
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Myocardial Infarction Associated Transcript (MIAT): Review of its impact in the tumorigenesis.
    Ghafouri-Fard S; Azimi T; Taheri M
    Biomed Pharmacother; 2021 Jan; 133():111040. PubMed ID: 33378948
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Long non-coding RNA MALAT1 facilitates the tumorigenesis, invasion and glycolysis of multiple myeloma via miR-1271-5p/SOX13 axis.
    Liu N; Feng S; Li H; Chen X; Bai S; Liu Y
    J Cancer Res Clin Oncol; 2020 Feb; 146(2):367-379. PubMed ID: 31953613
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [IL-6 Regulates the Chemosensitivity of Drug-Resistant Multiple Myeloma Cell Lines to Bortezomib through STAT3/Notch Signaling Pathway].
    Liu Y; Sui JZ; Zhu LH; Dai Y; Dong HQ; Cheng P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1474-1481. PubMed ID: 36208252
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The long noncoding RNA myocardial infarction-associated transcript modulates the epithelial-mesenchymal transition in renal interstitial fibrosis.
    Wang Z; Zhang B; Chen Z; He Y; Ru F; Liu P; Chen X
    Life Sci; 2020 Jan; 241():117187. PubMed ID: 31863776
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Impaired bortezomib binding to mutant β5 subunit of the proteasome is the underlying basis for bortezomib resistance in leukemia cells.
    Franke NE; Niewerth D; Assaraf YG; van Meerloo J; Vojtekova K; van Zantwijk CH; Zweegman S; Chan ET; Kirk CJ; Geerke DP; Schimmer AD; Kaspers GJ; Jansen G; Cloos J
    Leukemia; 2012 Apr; 26(4):757-68. PubMed ID: 21941364
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Long noncoding RNA MIR31HG exhibits oncogenic property in pancreatic ductal adenocarcinoma and is negatively regulated by miR-193b.
    Yang H; Liu P; Zhang J; Peng X; Lu Z; Yu S; Meng Y; Tong WM; Chen J
    Oncogene; 2016 Jul; 35(28):3647-57. PubMed ID: 26549028
    [TBL] [Abstract][Full Text] [Related]  

  • 68. DUT enhances drug resistance to proteasome inhibitors via promoting mitochondrial function in multiple myeloma.
    Wang Y; Gao S; Chen L; Liu S; Ma J; Cao Z; Li Q
    Carcinogenesis; 2022 Dec; 43(11):1030-1038. PubMed ID: 36426924
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A novel M phase blocker, DCZ3301 enhances the sensitivity of bortezomib in resistant multiple myeloma through DNA damage and mitotic catastrophe.
    Hu L; Li B; Chen G; Song D; Xu Z; Gao L; Xi M; Zhou J; Li L; Zhang H; Feng Q; Wang Y; Lu K; Lu Y; Bu W; Wang H; Wu X; Zhu W; Shi J
    J Exp Clin Cancer Res; 2020 Jun; 39(1):105. PubMed ID: 32517809
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Icaritin Reverses Multidrug Resistance of Multiple Myeloma Cell Line KM3/BTZ].
    Li ZY; Li ZJ; Chen X; Huang XR; Fang ZQ; Zhang JG; Fang J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Dec; 25(6):1690-1695. PubMed ID: 29262899
    [TBL] [Abstract][Full Text] [Related]  

  • 71. β-Catenin Inhibitor BC2059 Is Efficacious as Monotherapy or in Combination with Proteasome Inhibitor Bortezomib in Multiple Myeloma.
    Savvidou I; Khong T; Cuddihy A; McLean C; Horrigan S; Spencer A
    Mol Cancer Ther; 2017 Sep; 16(9):1765-1778. PubMed ID: 28500235
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Long noncoding RNA myocardial infarction associated transcript promotes the development of thoracic aortic by targeting microRNA-145 via the PI3K/Akt signaling pathway.
    Chen S; Chen H; Yu C; Lu R; Song T; Wang X; Tang W; Gao Y
    J Cell Biochem; 2019 Sep; 120(9):14405-14413. PubMed ID: 30989723
    [TBL] [Abstract][Full Text] [Related]  

  • 73. ATF4 destabilizes RET through nonclassical GRP78 inhibition to enhance chemosensitivity to bortezomib in human osteosarcoma.
    Luo J; Xia Y; Yin Y; Luo J; Liu M; Zhang H; Zhang C; Zhao Y; Yang L; Kong L
    Theranostics; 2019; 9(21):6334-6353. PubMed ID: 31534554
    [No Abstract]   [Full Text] [Related]  

  • 74. lncRNA MIAT functions as a competing endogenous RNA to upregulate DAPK2 by sponging miR-22-3p in diabetic cardiomyopathy.
    Zhou X; Zhang W; Jin M; Chen J; Xu W; Kong X
    Cell Death Dis; 2017 Jul; 8(7):e2929. PubMed ID: 28703801
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Long Non-Coding RNA MEG3 Functions as a Competing Endogenous RNA to Regulate HOXA11 Expression by Sponging miR-181a in Multiple Myeloma.
    Shen X; Bai H; Zhu H; Yan Q; Yang Y; Yu W; Shi Q; Wang J; Li J; Chen L
    Cell Physiol Biochem; 2018; 49(1):87-100. PubMed ID: 30134227
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Endoplasmic-reticulum stress pathway-associated mechanisms of action of proteasome inhibitors in multiple myeloma.
    Ri M
    Int J Hematol; 2016 Sep; 104(3):273-80. PubMed ID: 27169614
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Long non-coding RNA NEAT1 serves as a novel biomarker for treatment response and survival profiles via microRNA-125a in multiple myeloma.
    Yu H; Peng S; Chen X; Han S; Luo J
    J Clin Lab Anal; 2020 Sep; 34(9):e23399. PubMed ID: 32608537
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Long Noncoding RNA LUCAT1 Promotes Multiple Myeloma Cell Growth by Regulating the TGF-β Signaling Pathway.
    Liu Z; Gao H; Peng Q; Yang Y
    Technol Cancer Res Treat; 2020; 19():1533033820945770. PubMed ID: 32812490
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Long Intergenic Noncoding RNA 00152 Promotes Glioma Cell Proliferation and Invasion by Interacting with MiR-16.
    Chen X; Li D; Gao Y; Tang W; Iw L; Cao Y; Hao B
    Cell Physiol Biochem; 2018; 46(3):1055-1064. PubMed ID: 29669323
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Effects of PSMB5 on proliferation and bortezomib chemo-resistance in human myeloma cells and its related molecular mechanisms].
    Mo HM; Wu QY; Han DY; Liu R; Ma X; Zhou P; Xu KL
    Zhonghua Xue Ye Xue Za Zhi; 2017 Dec; 38(12):1053-1057. PubMed ID: 29365400
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.